Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Fish Oil Supplementation with Low-dose Isotretinoin for Moderate-to-severe Acne Vulgaris
TCTR20240810002Phase 3Completed
- Sponsor
- Ratchadaphiseksomphot Endowment Fund
- Start
- Jun 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of isotretinoin and fish oil concentrate in acne vulgaris (2 arms), sponsored by Ratchadaphiseksomphot Endowment Fund. Primary endpoints: Acne treatment efficacy and Isotretinoin side effects. Started Jun 2024; status: completed.
02
Drugs
isotretinoinfish oil concentrate
03
Conditions
acne vulgaris
Beyond the preview
Go deeper on TCTR20240810002.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on TCTR20240810002.